Sale!

DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the DNAAF3 gene responsible for Primary Ciliary Dyskinesia Type 2. This specialized test uses Next-Generation Sequencing technology to detect genetic abnormalities affecting ciliary function, which can lead to chronic respiratory infections, sinusitis, bronchiectasis, and fertility challenges. The test provides crucial information for accurate diagnosis, enabling targeted treatment strategies and genetic counseling. Available for only $500 USD, this advanced genetic analysis helps patients and healthcare providers understand the underlying causes of persistent respiratory symptoms and develop personalized management plans.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test

Comprehensive Genetic Testing for Ciliary Disorders

Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder affecting the structure and function of cilia, the microscopic hair-like structures that line the respiratory tract, reproductive system, and other organs. The DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics, offering precise identification of mutations in the DNAAF3 gene that cause this specific subtype of PCD.

What Does This Test Measure?

This advanced genetic test utilizes Next-Generation Sequencing (NGS) technology to comprehensively analyze the DNAAF3 gene for mutations associated with Primary Ciliary Dyskinesia Type 2. The test specifically detects:

  • Point mutations, deletions, and insertions in the DNAAF3 gene
  • Genetic variations affecting ciliary assembly factor 3 protein function
  • Mutations that disrupt normal ciliary motility and clearance mechanisms
  • Inherited genetic patterns associated with autosomal recessive PCD

Who Should Consider This Test?

This genetic test is recommended for individuals experiencing persistent symptoms that may indicate Primary Ciliary Dyskinesia, including:

  • Chronic respiratory infections beginning in infancy or childhood
  • Persistent nasal congestion and sinusitis
  • Recurrent middle ear infections and hearing loss
  • Chronic cough with excessive mucus production
  • Bronchiectasis or abnormal lung development
  • Infertility issues in males due to impaired sperm motility
  • Family history of Primary Ciliary Dyskinesia or related disorders
  • Situs inversus (organs positioned on opposite sides of the body)

Benefits of DNAAF3 Genetic Testing

Undergoing the DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 test provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Confirms or rules out PCD Type 2 with high precision
  • Personalized Treatment: Enables targeted management strategies for respiratory symptoms
  • Genetic Counseling: Provides essential information for family planning and inheritance risks
  • Early Intervention: Facilitates proactive management to prevent complications
  • Comprehensive Analysis: Uses advanced NGS technology for thorough genetic assessment
  • Peace of Mind: Reduces diagnostic uncertainty and provides clear answers

Understanding Your Test Results

Your DNAAF3 genetic test results will be carefully interpreted by our team of genetic specialists and ENT doctors. The report will indicate:

  • Positive Result: Identifies specific DNAAF3 mutations confirming Primary Ciliary Dyskinesia Type 2 diagnosis
  • Negative Result: No mutations detected in the DNAAF3 gene, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation

All results include detailed explanations and recommendations for next steps, including consultation with ENT specialists and genetic counselors to develop appropriate management strategies.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Availability

We have convenient testing locations across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art genetic testing facilities ensure consistent, high-quality results regardless of your location.

Take Control of Your Health Today

Don’t let unexplained respiratory symptoms or family history concerns remain unanswered. The DNAAF3 Gene Primary Ciliary Dyskinesia Type 2 NGS Genetic DNA Test provides the clarity you need for proper diagnosis and management. Our team of genetic specialists and ENT doctors are ready to help you understand your genetic profile and develop an effective treatment plan.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic testing appointment or to speak with our genetic counseling team. Take the first step toward understanding your genetic health and achieving better respiratory wellness.